1. Home
  2. MAN vs VIR Comparison

MAN vs VIR Comparison

Compare MAN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

HOLD

Current Price

$51.73

Market Cap

1.4B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.42

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAN
VIR
Founded
1948
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
MAN
VIR
Price
$51.73
$9.42
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$35.67
$19.43
AVG Volume (30 Days)
1.2M
2.4M
Earning Date
04-16-2026
05-06-2026
Dividend Yield
4.69%
N/A
EPS Growth
N/A
17.49
EPS
0.05
N/A
Revenue
$17,957,100,000.00
$68,556,000.00
Revenue This Year
$5.12
$270.22
Revenue Next Year
$3.42
N/A
P/E Ratio
$1,062.20
N/A
Revenue Growth
0.58
N/A
52 Week Low
$25.15
$4.16
52 Week High
$55.70
$11.66

Technical Indicators

Market Signals
Indicator
MAN
VIR
Relative Strength Index (RSI) 75.35 46.94
Support Level $27.11 $8.40
Resistance Level N/A $10.33
Average True Range (ATR) 2.58 0.49
MACD 1.48 -0.11
Stochastic Oscillator 80.35 21.09

Price Performance

Historical Comparison
MAN
VIR

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: